Caren Chancey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Caren Chancey has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
- Andriyan Grinev
Laboratory of Emerging Pathogens (LEP), Division of Emerging and Transfusion Transmitted Diseases (DETTD), Office of Blood Research and Review (OBRR), Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Silver Spring, MD, United States
2 shared publications - Evgeniya Volkova
Office of Blood Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland
2 shared publications - Maria Rios
Office of Blood Research and Review, Center for Biologics Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland
2 shared publications Vladimir Chizhikov
Laboratory of Method Development (LMD), Division of Viral Products (DVP), Office of Vaccine Research and Review (OVRR), CBER, FDA, Silver Spring, MD, United States
1 shared publication
Latest Publications
- 1 January 2017
- Published by Elsevier in Journal of Virological Methods
- Vol. 239, 17-25
Development of a microarray-based assay for rapid monitoring of genetic variants of West Nile virus circulating in the United States
- 1 January 2017
- Published by Elsevier in Journal of Virological Methods
- Vol. 239, 17-25
Development of a microarray-based assay for rapid monitoring of genetic variants of West Nile virus circulating in the United States
- Top Cited PapersOpen Access
- 19 March 2015
- Published by Wiley in BioMed Research International
- Vol. 2015, 1-20
The Global Ecology and Epidemiology of West Nile Virus
Since its initial isolation in Uganda in 1937 through the present, West Nile virus (WNV) has become an important cause of human and animal disease worldwide. WNV, an enveloped virus of the genusFlavivirus, is naturally maintained in an enzootic cycle between birds and mosquitoes, with occasional epizootic spillover causing disease in humans and horses. The mosquito vectors for WNV are widely distributed worldwide, and the known geographic range of WNV transmission and disease has continued to increase over the past 77 years. While most human infections with WNV are asymptomatic, severe neurological disease may develop resulting in long-term sequelae or death. Surveillance and preventive measures are an ongoing need to reduce the public health impact of WNV in areas with the potential for transmission.
- 19 March 2015
- Published by Wiley in BioMed Research International
- Vol. 2015, 1-20
Top Cited PapersOpen AccessThe Global Ecology and Epidemiology of West Nile Virus
Since its initial isolation in Uganda in 1937 through the present, West Nile virus (WNV) has become an important cause of human and animal disease worldwide. WNV, an enveloped virus of the genusFlavivirus, is naturally maintained in an enzootic cycle between birds and mosquitoes, with occasional epizootic spillover causing disease in humans and horses. The mosquito vectors for WNV are widely distributed worldwide, and the known geographic range of WNV transmission and disease has continued to increase over the past 77 years. While most human infections with WNV are asymptomatic, severe neurological disease may develop resulting in long-term sequelae or death. Surveillance and preventive measures are an ongoing need to reduce the public health impact of WNV in areas with the potential for transmission.